Haus vs. Aperol: why one failed and the other scaled
Haus had attention, investors and revenue. Aperol had a repeatable ritual. What their radically different paths reveal about growth, capital, distribution and business-model fit.
Clinical and strategic perspectives
Insights
Analyses, practical guidance and observations from work at the intersection of medicine, science, technology and business. The focus is on decisions that determine whether a healthcare innovation becomes clinically credible, operationally viable and useful in practice.
Prevent your project from failing
Recurring startup failure patterns are often visible before they become irreversible. This article examines ten of the most common causes and what healthcare innovators can do about them.
